Published in Nat Rev Endocrinol on August 09, 2011
Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell (2013) 3.10
Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut (2012) 3.09
Diversity of bifidobacteria within the infant gut microbiota. PLoS One (2012) 2.71
The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun (2013) 2.31
The pathophysiology of hypertension in patients with obesity. Nat Rev Endocrinol (2014) 2.13
Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes (2012) 1.83
Adaptive immunity in obesity and insulin resistance. Nat Rev Endocrinol (2012) 1.70
Identifying gut microbe-host phenotype relationships using combinatorial communities in gnotobiotic mice. Sci Transl Med (2014) 1.69
Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms. Bioessays (2014) 1.64
The vagus nerve and the inflammatory reflex--linking immunity and metabolism. Nat Rev Endocrinol (2012) 1.59
Assessing the fecal microbiota: an optimized ion torrent 16S rRNA gene-based analysis protocol. PLoS One (2013) 1.56
Intestinal permeability--a new target for disease prevention and therapy. BMC Gastroenterol (2014) 1.52
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS One (2012) 1.46
The impact of diet and lifestyle on gut microbiota and human health. Nutrients (2014) 1.40
Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J (2014) 1.34
The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. Annu Rev Med (2015) 1.33
Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci U S A (2014) 1.31
Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLoS One (2013) 1.26
Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J Biol Chem (2013) 1.25
Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients (2015) 1.18
Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury. Am J Physiol Gastrointest Liver Physiol (2012) 1.18
Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis. Neuropeptides (2012) 1.16
Microbial regulation of host hydrogen sulfide bioavailability and metabolism. Free Radic Biol Med (2013) 1.11
High-fat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects. PLoS One (2013) 1.10
The SCFA Receptor GPR43 and Energy Metabolism. Front Endocrinol (Lausanne) (2014) 1.09
The human gut microbiome and body metabolism: implications for obesity and diabetes. Clin Chem (2013) 1.07
Intestinal microbiota as modulators of the immune system and neuroimmune system: impact on the host health and homeostasis. J Immunol Res (2015) 1.06
Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model. PLoS One (2012) 1.04
Obesity and its associated disease: a role for microbiota? Neurogastroenterol Motil (2012) 1.03
Probiotics, prebiotics, and the host microbiome: the science of translation. Ann N Y Acad Sci (2013) 1.01
Coming full circle in diabetes mellitus: from complications to initiation. Nat Rev Endocrinol (2013) 1.01
Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals. PLoS One (2014) 1.00
Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice. Nutr Diabetes (2012) 0.99
The dormant blood microbiome in chronic, inflammatory diseases. FEMS Microbiol Rev (2015) 0.99
Interrelationships between ghrelin, insulin and glucose homeostasis: Physiological relevance. World J Diabetes (2014) 0.98
Gut microbiome and metabolic diseases. Semin Immunopathol (2013) 0.96
Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics. J Clin Invest (2014) 0.95
Metabolic diseases and pro- and prebiotics: Mechanistic insights. Nutr Metab (Lond) (2012) 0.94
The physiology underlying Roux-en-Y gastric bypass: a status report. Am J Physiol Regul Integr Comp Physiol (2014) 0.93
The role of metagenomics in understanding the human microbiome in health and disease. Virulence (2014) 0.93
Functional profiling of the gut microbiome in disease-associated inflammation. Genome Med (2013) 0.93
Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. Sci Rep (2015) 0.93
Correlation network analysis reveals relationships between diet-induced changes in human gut microbiota and metabolic health. Nutr Diabetes (2014) 0.92
How gut microbes talk to organs: The role of endocrine and nervous routes. Mol Metab (2016) 0.91
Prebiotic fiber modulation of the gut microbiota improves risk factors for obesity and the metabolic syndrome. Gut Microbes (2012) 0.91
Regulation of Energy Homeostasis by GPR41. Front Endocrinol (Lausanne) (2014) 0.89
Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders. Nutrients (2016) 0.87
Gender-specific metabolomic profiling of obesity in leptin-deficient ob/ob mice by 1H NMR spectroscopy. PLoS One (2013) 0.87
Curcuma longa extract associated with white pepper lessens high fat diet-induced inflammation in subcutaneous adipose tissue. PLoS One (2013) 0.87
Table grape consumption reduces adiposity and markers of hepatic lipogenesis and alters gut microbiota in butter fat-fed mice. J Nutr Biochem (2015) 0.87
Exploring the influence of the gut microbiota and probiotics on health: a symposium report. Br J Nutr (2014) 0.86
Immune disorders and its correlation with gut microbiome. Immune Netw (2012) 0.86
Modulation of the gut microbiota by nutrients with prebiotic and probiotic properties. Adv Nutr (2014) 0.86
Probiotics and chronic kidney disease. Kidney Int (2015) 0.86
The nonfermentable dietary fiber hydroxypropyl methylcellulose modulates intestinal microbiota. FASEB J (2012) 0.85
Impact of kefir derived Lactobacillus kefiri on the mucosal immune response and gut microbiota. J Immunol Res (2015) 0.85
The role of Gut Microbiota in the development of obesity and Diabetes. Lipids Health Dis (2016) 0.84
Hot topics in gut microbiota. United European Gastroenterol J (2013) 0.84
Gut Microbiota Modification: Another Piece in the Puzzle of the Benefits of Physical Exercise in Health? Front Physiol (2016) 0.82
American Diabetes Association and JDRF Research Symposium: Diabetes and the Microbiome. Diabetes (2015) 0.82
Chronic endocannabinoid system stimulation induces muscle macrophage and lipid accumulation in type 2 diabetic mice independently of metabolic endotoxaemia. PLoS One (2013) 0.82
Role of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the Literature. J Obes (2016) 0.81
Broad scope method for creating humanized animal models for animal health and disease research through antibiotic treatment and human fecal transfer. Gut Microbes (2014) 0.81
The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviour. Acta Physiol (Oxf) (2015) 0.81
Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study. J Natl Cancer Inst (2015) 0.81
Type 2 diabetes and gut microbiome: at the intersection of known and unknown. Gut Microbes (2015) 0.81
An analysis of the role of the indigenous microbiota in cholesterol gallstone pathogenesis. PLoS One (2013) 0.81
Obesity, Asthma, and the Microbiome. Physiology (Bethesda) (2016) 0.81
Apple-Derived Pectin Modulates Gut Microbiota, Improves Gut Barrier Function, and Attenuates Metabolic Endotoxemia in Rats with Diet-Induced Obesity. Nutrients (2016) 0.81
High-intensity exercise training increases the diversity and metabolic capacity of the mouse distal gut microbiota during diet-induced obesity. Am J Physiol Endocrinol Metab (2016) 0.80
How the microbiota shapes rheumatic diseases. Nat Rev Rheumatol (2016) 0.80
Probiotics during weaning: a follow-up study on effects on body composition and metabolic markers at school age. Eur J Nutr (2014) 0.80
Nutritional Signaling via Free Fatty Acid Receptors. Int J Mol Sci (2016) 0.79
Gut Microbiota and Lifestyle Interventions in NAFLD. Int J Mol Sci (2016) 0.79
Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. BMC Immunol (2017) 0.79
High-fat diet feeding differentially affects the development of inflammation in the central nervous system. J Neuroinflammation (2016) 0.79
The associations between yogurt consumption, diet quality, and metabolic profiles in children in the USA. Eur J Nutr (2014) 0.78
Caesarean section and adiposity at 6, 18 and 30 years of age: results from three Pelotas (Brazil) birth cohorts. BMC Public Health (2017) 0.78
Anti-obesogenic and antidiabetic effects of plants and mushrooms. Nat Rev Endocrinol (2016) 0.78
Gut microbiota Modulated by Probiotics and Garcinia cambogia Extract Correlate with Weight Gain and Adipocyte Sizes in High Fat-Fed Mice. Sci Rep (2016) 0.78
Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice. Mucosal Immunol (2016) 0.78
Prebiotics Modulate the Effects of Antibiotics on Gut Microbial Diversity and Functioning in Vitro. Nutrients (2015) 0.78
A novel cobiotic-based preventive approach against high-fat diet-induced adiposity, nonalcoholic fatty liver and gut derangement in mice. Int J Obes (Lond) (2015) 0.78
The Role of Gut Microflora and the Cholinergic Anti-inflammatory Neuroendocrine System in Diabetes Mellitus. Front Endocrinol (Lausanne) (2016) 0.78
Gut Microbiota and Metabolic Health: The Potential Beneficial Effects of a Medium Chain Triglyceride Diet in Obese Individuals. Nutrients (2016) 0.78
Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkers. BMC Complement Altern Med (2017) 0.77
Selective Spectrum Antibiotic Modulation of the Gut Microbiome in Obesity and Diabetes Rodent Models. PLoS One (2015) 0.77
Obesity and Asthma: Microbiome-Metabolome Interactions. Am J Respir Cell Mol Biol (2016) 0.77
The role of the gut microbiome in the pathogenesis and treatment of obesity. Glob Adv Health Med (2014) 0.77
Intestinal Sucrase as a Novel Target Contributing to the Regulation of Glycemia by Prebiotics. PLoS One (2016) 0.77
Effect of Lactobacillus plantarum FH185 on the Reduction of Adipocyte Size and Gut Microbial Changes in Mice with Diet-induced Obesity. Korean J Food Sci Anim Resour (2015) 0.76
A polyphenol-rich fraction obtained from table grapes decreases adiposity, insulin resistance and markers of inflammation and impacts gut microbiota in high-fat-fed mice. J Nutr Biochem (2016) 0.76
Network modules and hubs in plant-root fungal biomes. J R Soc Interface (2016) 0.76
Circadian Rhythm Shapes the Gut Microbiota Affecting Host Radiosensitivity. Int J Mol Sci (2016) 0.76
Nutritional modulation of insulin resistance. Scientifica (Cairo) (2012) 0.76
Lactobacillus rhamnosus GG improves glucose tolerance through alleviating ER stress and suppressing macrophage activation in db/db mice. J Clin Biochem Nutr (2015) 0.76
Does Whole Grain Consumption Alter Gut Microbiota and Satiety? Healthcare (Basel) (2015) 0.76
Can probiotics modulate human disease by impacting intestinal barrier function? Br J Nutr (2017) 0.75
A core gut microbiome in obese and lean twins. Nature (2008) 52.30
An obesity-associated gut microbiome with increased capacity for energy harvest. Nature (2006) 44.35
A human gut microbial gene catalogue established by metagenomic sequencing. Nature (2010) 43.63
Microbial ecology: human gut microbes associated with obesity. Nature (2006) 36.98
Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A (2005) 33.66
The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A (2004) 26.56
The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med (2009) 16.02
Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes (2007) 14.12
Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science (2010) 12.54
Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature (2008) 12.45
Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe (2008) 11.97
Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A (2010) 11.21
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes (2008) 10.74
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A (2007) 9.71
Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell (2006) 9.64
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut (2009) 6.50
Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One (2010) 6.48
Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) (2009) 6.12
Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature (2010) 5.92
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia (2007) 5.61
Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut (2004) 5.32
High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology (2009) 5.08
Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J Lipid Res (2002) 4.94
Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond) (2008) 4.78
Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science (2009) 4.45
Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A (2008) 4.45
A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr (2007) 4.34
Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab (2006) 3.84
Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol (2006) 3.59
The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem (2005) 3.51
Prebiotic effects: metabolic and health benefits. Br J Nutr (2010) 3.49
Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes (2010) 3.39
Obesity and the human microbiome. Curr Opin Gastroenterol (2010) 3.38
Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res (2008) 3.27
Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr (2008) 3.25
Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol (2010) 2.84
Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care (2009) 2.83
Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr (2008) 2.77
The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des (2009) 2.65
Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB J (2010) 2.19
Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br J Nutr (2010) 2.17
Colonization-induced host-gut microbial metabolic interaction. MBio (2011) 2.04
Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr (2009) 2.00
Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol (2010) 1.92
Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr (2009) 1.90
Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. Am J Physiol Endocrinol Metab (2010) 1.90
Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes (2006) 1.83
Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats. Lab Anim Sci (1983) 1.82
Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr (2010) 1.82
The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol (2010) 1.79
Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opin Pharmacol (2009) 1.67
Mucin-bacterial interactions in the human oral cavity and digestive tract. Gut Microbes (2010) 1.65
Genotype is a stronger determinant than sex of the mouse gut microbiota. Microb Ecol (2010) 1.63
Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care (2010) 1.61
Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. Br J Nutr (2004) 1.55
Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1. Obes Res (2005) 1.50
Regulation of serum amyloid A3 (SAA3) in mouse colonic epithelium and adipose tissue by the intestinal microbiota. PLoS One (2009) 1.47
Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity (Silver Spring) (2010) 1.47
Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS One (2010) 1.43
Effects of the gut microbiota on obesity and glucose homeostasis. Trends Endocrinol Metab (2011) 1.43
Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. J Nutr Biochem (2010) 1.30
Oligofructose promotes satiety in healthy human: a pilot study. Eur J Clin Nutr (2006) 1.30
Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. Am J Clin Nutr (2010) 1.29
Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. J Nutr Biochem (2010) 1.26
Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br J Nutr (2007) 1.25
Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. Cardiovasc Diabetol (2009) 1.22
Intestinal microbiota during infancy and its implications for obesity. J Pediatr Gastroenterol Nutr (2009) 1.22
Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr (2010) 1.16
Acute-phase serum amyloid A as a marker of insulin resistance in mice. Exp Diabetes Res (2008) 1.11
Probiotics - little evidence for a link to obesity. Nat Rev Microbiol (2009) 1.09
The endocannabinoid system and its relevance for nutrition. Annu Rev Nutr (2010) 1.09
No causal link between obesity and probiotics. Nat Rev Microbiol (2009) 1.05
Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance. Eur J Clin Nutr (2006) 1.03
Arabinoxylan fibre improves metabolic control in people with Type II diabetes. Eur J Clin Nutr (2004) 1.01
Diversity and metabolic impact of intestinal Lactobacillus species in healthy adults and the elderly. Br J Nutr (2011) 0.99
Pilot study: alterations of intestinal microbiota in obese humans are not associated with colonic inflammation or disturbances of barrier function. Aliment Pharmacol Ther (2010) 0.98
Effect of the orlistat on serum endotoxin lipopolysaccharide and adipocytokines in South Asian individuals with impaired glucose tolerance. Int J Clin Pract (2008) 0.98
Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study. Eur J Clin Nutr (2005) 0.97
Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics. J Nutr (2000) 0.97
Potential interest of gut microbial changes induced by non-digestible carbohydrates of wheat in the management of obesity and related disorders. Curr Opin Clin Nutr Metab Care (2010) 0.91
Acquisition, evolution and maintenance of the normal gut microbiota. Dig Dis (2010) 0.91
Human microbiome: take-home lesson on growth promoters? Nature (2008) 0.90
Arabinoxylan fibre consumption improved glucose metabolism, but did not affect serum adipokines in subjects with impaired glucose tolerance. Horm Metab Res (2006) 0.84
Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A (2005) 33.66
Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One (2008) 14.63
Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes (2007) 14.12
Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe (2008) 11.97
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes (2008) 10.74
Functional interactions between the gut microbiota and host metabolism. Nature (2012) 7.91
Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature (2013) 6.07
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A (2013) 5.88
The gut microbiota--masters of host development and physiology. Nat Rev Microbiol (2013) 5.25
Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab (2013) 4.88
Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell (2012) 4.86
Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature (2012) 4.04
Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell (2007) 3.82
Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A (2010) 3.51
Prebiotic effects: metabolic and health benefits. Br J Nutr (2010) 3.49
Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut (2012) 3.09
Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J (2008) 2.97
The gut microbiota regulates bone mass in mice. J Bone Miner Res (2012) 2.92
Drosophila genome-wide obesity screen reveals hedgehog as a determinant of brown versus white adipose cell fate. Cell (2010) 2.91
Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun (2012) 2.84
Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr (2008) 2.77
Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest (2009) 2.75
Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88. Gut (2011) 2.67
The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res (2009) 2.59
Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes (2011) 2.46
Microbial modulation of energy availability in the colon regulates intestinal transit. Cell Host Microbe (2013) 2.14
Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. J Clin Invest (2005) 2.01
Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr (2009) 2.00
Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice. Gut (2012) 1.99
Kupffer cell activation is a causal factor for hepatic insulin resistance. Am J Physiol Gastrointest Liver Physiol (2009) 1.85
Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin. Endocrinology (2006) 1.81
The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol (2010) 1.79
Interaction between obesity and the gut microbiota: relevance in nutrition. Annu Rev Nutr (2011) 1.72
Hedgehog partial agonism drives Warburg-like metabolism in muscle and brown fat. Cell (2012) 1.65
Assessing the human gut microbiota in metabolic diseases. Diabetes (2013) 1.64
Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1. Obes Res (2005) 1.50
Age-dependent TLR3 expression of the intestinal epithelium contributes to rotavirus susceptibility. PLoS Pathog (2012) 1.48
Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab (2008) 1.48
Regulation of serum amyloid A3 (SAA3) in mouse colonic epithelium and adipose tissue by the intestinal microbiota. PLoS One (2009) 1.47
Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol (2013) 1.47
Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Front Microbiol (2011) 1.46
Effects of the gut microbiota on obesity and glucose homeostasis. Trends Endocrinol Metab (2011) 1.43
Nanoscale features influence epithelial cell morphology and cytokine production. Biomaterials (2003) 1.38
Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PLoS One (2011) 1.37
Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: experimental data. J Nutr (2007) 1.32
Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. J Nutr Biochem (2010) 1.30
Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice. J Nutr Biochem (2011) 1.30
Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling. Nature (2012) 1.29
Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation. FASEB J (2011) 1.29
Lactobacillus reuteri prevents diet-induced obesity, but not atherosclerosis, in a strain dependent fashion in Apoe-/- mice. PLoS One (2012) 1.27
Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure. Endocrinology (2008) 1.25
Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis. PLoS One (2009) 1.25
Initial dietary and microbiological environments deviate in normal-weight compared to overweight children at 10 years of age. J Pediatr Gastroenterol Nutr (2011) 1.24
Impact of inulin and oligofructose on gastrointestinal peptides. Br J Nutr (2005) 1.23
Linkage between cellular communications, energy utilization, and proliferation in metastatic neuroendocrine cancers. Proc Natl Acad Sci U S A (2006) 1.23
Role of central nervous system glucagon-like Peptide-1 receptors in enteric glucose sensing. Diabetes (2008) 1.22
Intestinal microbiota during infancy and its implications for obesity. J Pediatr Gastroenterol Nutr (2009) 1.22
Intestinal permeability is associated with visceral adiposity in healthy women. Obesity (Silver Spring) (2011) 1.21
Physiological effects of dietary fructans extracted from Agave tequilana Gto. and Dasylirion spp. Br J Nutr (2007) 1.17
Hypothalamic AgRP-neurons control peripheral substrate utilization and nutrient partitioning. EMBO J (2012) 1.17
Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact (2011) 1.16
Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice. Biochem Pharmacol (2009) 1.14
Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide. Br J Nutr (2004) 1.12
The unfolded protein response is activated in skeletal muscle by high-fat feeding: potential role in the downregulation of protein synthesis. Am J Physiol Endocrinol Metab (2010) 1.09
Gut microbiota and metabolic disorders: How prebiotic can work? Br J Nutr (2013) 1.09
Microbial modulation of insulin sensitivity. Cell Metab (2014) 1.08
Peroxisome proliferator-activated receptor-alpha-null mice have increased white adipose tissue glucose utilization, GLUT4, and fat mass: Role in liver and brain. Endocrinology (2006) 1.08
Relation between colonic proglucagon expression and metabolic response to oligofructose in high fat diet-fed mice. Life Sci (2006) 1.08
Critical role of Kupffer cells in the management of diet-induced diabetes and obesity. Biochem Biophys Res Commun (2009) 1.07
SREBP-1 regulates the expression of heme oxygenase 1 and the phosphatidylinositol-3 kinase regulatory subunit p55 gamma. J Lipid Res (2007) 1.05
A place for dietary fibre in the management of the metabolic syndrome. Curr Opin Clin Nutr Metab Care (2005) 1.05
Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model. PLoS One (2012) 1.04
Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet. FASEB J (2011) 1.04
Hepatic n-3 polyunsaturated fatty acid depletion promotes steatosis and insulin resistance in mice: genomic analysis of cellular targets. PLoS One (2011) 1.03
Toll-like receptor 4 knockout mice are protected against endoplasmic reticulum stress induced by a high-fat diet. PLoS One (2013) 1.02
Deletion of Lkb1 in pro-opiomelanocortin neurons impairs peripheral glucose homeostasis in mice. Diabetes (2011) 1.02
Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects. Brain Behav Immun (2012) 1.02
Gut microbiota and the pathogenesis of insulin resistance. Curr Diab Rep (2011) 1.02
Central insulin regulates heart rate and arterial blood flow: an endothelial nitric oxide synthase-dependent mechanism altered during diabetes. Diabetes (2007) 1.01
Probiotics, prebiotics, and the host microbiome: the science of translation. Ann N Y Acad Sci (2013) 1.01
Gut microbiota affects lens and retinal lipid composition. Exp Eye Res (2009) 1.00
Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6. Proc Natl Acad Sci U S A (2013) 1.00
Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life. Cell Host Microbe (2015) 0.99
The gut microbiota reduces leptin sensitivity and the expression of the obesity-suppressing neuropeptides proglucagon (Gcg) and brain-derived neurotrophic factor (Bdnf) in the central nervous system. Endocrinology (2013) 0.99
Expression of the blood-group-related glycosyltransferase B4galnt2 influences the intestinal microbiota in mice. ISME J (2012) 0.98